文献速递冠心病血脂与心血管预防

高心血管风险人群中功能失调的高密度脂蛋白与急性冠脉综合征发病率增加相关:一项巢式病例对照研究

Dysfunctional High-Density Lipoproteins Are Associated With a Greater Incidence of Acute Coronary Syndrome in a Population at High Cardiovascular Risk: A Nested Case-Control Study.
PubMed 文献 · Circulation · 2020-01-16

该研究在PREDIMED队列中开展巢式病例对照研究,167例急性冠脉综合征患者按1:2匹配对照,检测HDL功能特征。结果显示胆固醇流出能力低、氧化炎症指数高及S1P和ApoA-I水平低与急性冠脉综合征风险增加相关。

要点

  • 低胆固醇流出能力和低S1P、ApoA-I水平与急性冠脉综合征风险增加相关。
  • 高HDL氧化炎症指数与不稳定型心绞痛风险相关。
  • HDL功能特征而非胆固醇浓度可能反映心血管风险。

核心结论

  • 低胆固醇流出能力、促氧化/促炎HDL颗粒以及低S1P和ApoA-I水平与高心血管风险个体急性冠脉综合征及其表现的风险增加相关。

研究设计与样本

  • 在PREDIMED随机试验队列中开展巢式病例对照研究,167例急性冠脉综合征患者按性别、年龄、干预组、BMI和随访时间1:2匹配对照。

主要发现

  • 低胆固醇流出能力(OR1SD 0.58; 95%CI 0.40-0.83)和低S1P(OR1SD 0.70; 95%CI 0.52-0.92)及低ApoA-I(OR1SD 0.58; 95%CI 0.42-0.79)与急性冠脉综合征风险增加相关。
  • 高HDL氧化炎症指数与急性冠脉综合征风险边缘相关(OR1SD 1.27; 95%CI 0.99-1.63)。
  • 低胆固醇流出能力(OR1SD 0.33; 95%CI 0.18-0.61)、低S1P(OR1SD 0.60; 95%CI 0.40-0.89)和低ApoA-I(OR1SD 0.59; 95%CI 0.37-0.93)与心肌梗死相关。
  • 高HDL氧化炎症指数(OR1SD 1.53; 95%CI 1.01-2.33)和低ApoA-I(OR1SD 0.52; 95%CI 0.31-0.88)与不稳定型心绞痛相关。

临床怎么用

  • 在高心血管风险人群中,评估HDL功能特征如胆固醇流出能力可能有助于风险分层。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Studies have failed to establish a clear link between high-density lipoprotein (HDL) cholesterol and cardiovascular disease, leading to the hypothesis that the atheroprotective role of HDL lies in its biological activity rather than in its cholesterol content. However, to date, the association between HDL functional characteristics and acute coronary syndrome has not been investigated comprehensively. METHODS: We conducted a case-control study nested within the PREDIMED (Prevención con Dieta Mediterránea) cohort, originally a randomized trial in which participants followed a Mediterranean or low-fat diet. Incident acute coronary syndrome cases (N=167) were individually matched (1:2) to control patients by sex, age, intervention group, body mass index, and follow-up time. We investigated 2 individual manifestations (myocardial infarction, unstable angina) as secondary outcomes. We measured the following functional characteristics: HDL cholesterol concentration (in plasma); cholesterol efflux capacity; antioxidant ability, measured by the HDL oxidative-inflammatory index; phospholipase A2 activity; and sphingosine-1-phosphate, apolipoproteins A-I and A-IV, serum amyloid A, and complement 3 protein (in apolipoprotein B-depleted plasma). We used conditional logistic regression models adjusted for HDL cholesterol levels and cardiovascular risk factors to estimate odds ratios (ORs) between 1-SD increments in HDL functional characteristics and clinical outcomes. RESULTS: Low values of cholesterol efflux capacity (OR1SD, 0.58; 95% CI, 0.40-0.83) and low levels of sphingosine-1-phosphate (OR1SD, 0.70; 95% CI, 0.52-0.92) and apolipoprotein A-I (OR1SD, 0.58; 95% CI, 0.42-0.79) were associated with higher odds of acute coronary syndrome. Higher HDL oxidative inflammatory index values were marginally linked to acute coronary syndrome risk (OR1SD, 1.27; 95% CI, 0.99-1.63). Low values of cholesterol efflux capacity (OR1SD, 0.33; 95% CI, 0.18-0.61), sphingosine-1-phosphate (OR1SD: 0.60; 95% CI: 0.40-0.89), and apolipoprotein A-I (OR1SD, 0.59; 95% CI, 0.37-0.93) were particularly linked to myocardial infarction, whereas high HDL oxidative-inflammatory index values (OR1SD, 1.53; 95% CI, 1.01-2.33) and low apolipoprotein A-I levels (OR1SD, 0.52; 95% CI, 0.31-0.88) were associated with unstable angina. CONCLUSIONS: Low cholesterol efflux capacity values, pro-oxidant/proinflammatory HDL particles, and low HDL levels of sphingosine-1-phosphate and apolipoprotein A-I were associated with increased odds of acute coronary syndrome and its manifestations in individuals at high cardiovascular risk. CLINICAL TRIAL REGISTRATION: URL: https://www.controlled-trials.com/ISRCTN35739639. Unique identifier: ISRCTN35739639.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Soria-Florido MT, Castañer O, Lassale C, et al. Dysfunctional High-Density Lipoproteins Are Associated With a Greater Incidence of Acute Coronary Syndrome in a Population at High Cardiovascular Risk: A Nested Case-Control Study. Circulation. 2020. PMID: 31941372. doi:10.1161/CIRCULATIONAHA.119.041658

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。